companydata.dkNUEVOLUTION A/S: Financial statements 2016
CVR: 26029708
NUEVOLUTION A/S (CVR 26029708) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 17,015,000 and a net result of DKK -104,854,000 compared with DKK -43,912,000 the year before. That is a decrease of 28.8% compared with the year before. The profit margin was -616.2%. Equity amounted to DKK 15,550,000. The solvency ratio was 34.9%.
- Revenue
- 17,015,000 kr.
- Gross Profit
- -37,425,000 kr.
- Profit/Loss
- -104,854,000 kr.
- Equity
- 15,550,000 kr.
- Total Assets
- 44,506,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 17 mio. | -37.4 mio. | -104.9 mio. | 15.6 mio. | - |
| 2015 | 23.9 mio. | -22.5 mio. | -43.9 mio. | 41.7 mio. | - |
How creditworthy is NUEVOLUTION A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of September 22, 2016, Thomas Franch is registered as director of NUEVOLUTION A/S.
As of September 22, 2016, Henrik Damkjær Simonsen is registered as director of NUEVOLUTION A/S.
As of September 22, 2016, Antonius Franciscus Berkien is registered as director of NUEVOLUTION A/S.
As of January 28, 2016, Viktor Drvota has left the board of directors of NUEVOLUTION A/S.
About NUEVOLUTION A/S
NUEVOLUTION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CHEMGENE ApS. The management consists of Thomas Franch. The company is owned by Amgen, Inc.. The company has 59 employees. In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. Equity amounted to DKK 89,493,000.